Glaucoma is a serious eye disease where increased pressure inside the eye damages the optic nerve. Your eye produces fluid called aqueous humor that maintains the eye's shape and nourishes it. Normally this fluid drains out through a network of tiny channels. With glaucoma, those drainage channels become blocked or less efficient, pressure builds up, and it can damage the optic nerve permanently. The scary part? Glaucoma often has no symptoms early on. People lose vision without realizing it's happening. That's why early detection is absolutely critical.
Primary open-angle glaucoma is the most common type, accounting for most glaucoma cases. The drainage angle is open but drainage is inefficient. Angle-closure glaucoma is rarer but more urgent; the drainage angle is physically blocked. Secondary glaucoma develops from other eye conditions or treatments. Risk factors include family history, age over 60, high eye pressure, thin corneas, nearsightedness, and diabetes. African Americans and Hispanics have higher risk. If glaucoma runs in your family, get screened regularly even if you have no symptoms.
Glaucoma is usually managed first with eye drops that either decrease fluid production or improve drainage. Different types of drops work different ways, and your eye doctor will find the right combination. Using drops consistently is key to controlling eye pressure and preventing vision loss. However, managing multiple eye drops every day can be challenging. Some people forget doses, or the drops cause side effects like eye redness or systemic effects. That's where newer treatments come in.
iDose TR is an exciting innovation for glaucoma patients. It's a tiny, micro-implant that sits in the eye and continuously releases glaucoma medication directly into the eye over time. Think of it as an automatic medication delivery system. You don't have to remember daily drops. You don't deal with side effects from eye drops. The implant delivers consistent medication to keep eye pressure controlled. Clinical trials show that about 80 percent of patients didn't need additional eye drops for at least 12 months after getting iDose TR. It's covered by Medicare and expected to be covered by commercial insurance soon.
iDose TR is perfect for people with open-angle glaucoma or ocular hypertension who are tired of daily eye drops, or who experience side effects from drops. It's also excellent if you forget to use drops consistently. The procedure is quick and minimally invasive. Your surgeon places the tiny implant in your eye. You go home the same day. There's minimal downtime. Many patients report life-changing relief from finally having automatic, hassle-free glaucoma management. If you're struggling with eye drops, ask your surgeon if iDose TR might be right for you.